Professor Julian Jack FRS, FMedSci, FRCP
Professor Jack was Professor of Physiology, University of Oxford from 1996-2003, and a Governor of the Wellcome Trust from 1987-2003 (Deputy Chairman of the Governors from 1994-99). He is distinguished for his outstanding theoretical and experimental contributions to the understanding of synaptic transmission in the central nervous system.
Dr Duncan Rogers
Dr Rogers is Reader in Respiratory Pharmacology and Recognised Teacher of the University of London (Physiology). He has just finished a term as the NHLI Director of Postgraduate Studies (Research). Dr Rogers' has a B.Sc. in Applied Biology (2:1 Hons.) from Brunel University, a Postgraduate Certificate in Education from University of London, and a Ph.D. in Physiology, University of London. He is a Fellow of the Institute of Biology and a member, and one-time Chairman, of the British Association for Lung Research. He is also a member of British Pharmacological Society and The Physiological Society, and has previously been a Member of the British Lung Foundation's Scientific Committee and a Member of the Public Relations Board of the Institute of Biology. Dr Rogers is currently Editor-in-Chief of Experimental Lung Research, and has previously been on the Editorial Boards of Thorax, the British Journal of Pharmacology, and Current Drug. He has published over 60 research papers, over 30 reviews and over 20 book chapters, as well as a number of editorials and electronic publications, and edited two books.
Professor Peter Goodfellow
Professor Goodfellow has worked for many years as a research scientist specialising in human genetics. His first independent position was at the Imperial Cancer Research Fund in London, where he worked for 13 years studying human gene mapping and the genetics of sex determination. In 1992, he was elected to the position of Balfour Professor of Genetics at Cambridge University. For the past decade, Peter worked in the pharmaceutical industry, serving as head of Discovery for SmithKline Beecham and Senior Vice-President of Discovery Research at GlaxoSmithKline.
Amongst other honours, Peter has been elected as a Fellow of The Royal Society and has been awarded the Louis Jeantet Prize for Medicine (with Dr R Lovell-Badge), the Francis Amory Prize (with Dr R.Lovell-Badge) and a Doctorate in Science (honoris causa) from Bristol University.